Active Removal of IntraCerebral Hematoma Via Active Irrigation

NCT05118997 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-08-01

No results posted yet for this study

Summary

Study evaluating if active irrigation by IRRAflow® with infusion of tPA will reduce the time needed for clearance of intracerebral and intraventricular hemorrhage compared with passive drainage.

Conditions

  • Cerebral Hemorrhage
  • Intraventricular Hemorrhage

Interventions

DEVICE

IRRAflow

IRRAflow consists of a control unit and disposables (dual-lumen catheter and tube set) to offer an integrated and synchronized active fluid exchange system. Active fluid exchange is the combination of traditional gravity-driven drainage with periodic, controlled irrigation of the catheter probe to exchange any pathological fluid collection with neutral physiological fluids.

DEVICE

EVD

An external ventricular drain (EVD), also known as a ventriculostomy or extraventricular drain, is a device used in neurosurgery to treat hydrocephalus and relieve elevated intracranial pressure when the normal flow of cerebrospinal fluid inside the brain is obstructed.

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER
  • Northwestern University

    collaborator OTHER
  • West Virginia University

    collaborator OTHER
  • Klinikum Bergmannstrost

    collaborator UNKNOWN
  • Stony Brook University Hospital

    collaborator UNKNOWN
  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER
  • Buffalo General Medical Center

    collaborator UNKNOWN
  • IRRAS

    lead INDUSTRY

Principal Investigators

  • Behnam Rezai Jahromi, MD · University of Helsinki

  • Babak Jahromi, MD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-25
Primary Completion
2025-07-31
Completion
2025-09-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05118997 on ClinicalTrials.gov